CareRay Digital Medical Technology Future Growth
Future criteria checks 5/6
CareRay Digital Medical Technology is forecast to grow earnings and revenue by 32.6% and 23.1% per annum respectively. EPS is expected to grow by 30.8% per annum. Return on equity is forecast to be 4.8% in 3 years.
Key information
32.6%
Earnings growth rate
30.8%
EPS growth rate
| Medical Equipment earnings growth | 23.2% |
| Revenue growth rate | 23.1% |
| Future return on equity | 4.8% |
| Analyst coverage | Low |
| Last updated | 20 May 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 525 | 54 | N/A | 29 | 1 |
| 12/31/2025 | 431 | 38 | N/A | 63 | 1 |
| 12/31/2024 | 345 | 29 | N/A | 15 | 1 |
| 6/30/2024 | 292 | 24 | -26 | 28 | N/A |
| 3/31/2024 | 277 | 23 | -9 | 36 | N/A |
| 12/31/2023 | 274 | 15 | -22 | 21 | N/A |
| 9/30/2023 | 243 | 1 | -37 | 12 | N/A |
| 6/30/2023 | 215 | -4 | -62 | -17 | N/A |
| 3/31/2023 | 217 | -5 | -60 | -30 | N/A |
| 12/31/2022 | 205 | -6 | -56 | -33 | N/A |
| 9/30/2022 | 234 | 18 | -37 | -19 | N/A |
| 6/30/2022 | 265 | 36 | -11 | 6 | N/A |
| 3/31/2022 | 291 | 55 | 0 | 17 | N/A |
| 12/31/2021 | 342 | 85 | 17 | 32 | N/A |
| 9/30/2021 | 361 | 93 | 29 | 41 | N/A |
| 6/30/2021 | 394 | 102 | 52 | 58 | N/A |
| 3/31/2021 | 386 | 95 | 55 | 61 | N/A |
| 12/31/2020 | 339 | 75 | 64 | 71 | N/A |
| 9/30/2020 | 325 | 64 | 61 | 68 | N/A |
| 12/31/2019 | 235 | 48 | 17 | 22 | N/A |
| 12/31/2018 | 213 | 49 | 30 | 33 | N/A |
| 12/31/2017 | 198 | 22 | N/A | 29 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688607's forecast earnings growth (32.6% per year) is above the savings rate (2.9%).
Earnings vs Market: 688607's earnings (32.6% per year) are forecast to grow faster than the CN market (22% per year).
High Growth Earnings: 688607's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688607's revenue (23.1% per year) is forecast to grow faster than the CN market (13.4% per year).
High Growth Revenue: 688607's revenue (23.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688607's Return on Equity is forecast to be low in 3 years time (4.8%).